This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
Episode 19: Takeaways from CDISC TMF US Interchange
Phase Forward
11 minutes 1 second
1 year ago
Episode 19: Takeaways from CDISC TMF US Interchange
Join the conversation with Amélie Rivet, Associate Director of eTMF Operations at Innovaderm. With extensive experience managing global trials across North America, Europe, and Asia, Amélie brings a deep understanding of the clinical steps essential for successful trials, from start-up to close-out. Well-versed in regulatory requirements and skilled in managing multidisciplinary teams, she will share key insights from the CDISC TMF US Interchange conference held in Arizona last October. Tune in to gain valuable knowledge and stay informed about the latest trends in TMF management.
Phase Forward
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
